Arnold Ravick
Podiatrist · Washington, DCNPI 1003870841
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $967 of the $1,082 with a category attached, or 89.4%. It is spread thinly across 12 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $445 and has fallen 68.2% since, to $141 in 2025.
Across 15 payments — averaging $72.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$192
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$190
- Bioventus LLC$132
- Organogenesis Inc.$115
- Biopro, Inc.$105
- Amgen$103
- plus $246 from 6 others
What the payments were for
- Speaking & faculty fees$11511%
- Food & beverage$96789%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 1 | $192 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $190 |
| Bioventus LLC | 1 | $132 |
| Organogenesis Inc. | 1 | $115 |
| Biopro, Inc. | 1 | $105 |
| Amgen | 1 | $103 |
| Orthofix Medical, Inc. | 1 | $89 |
| Alnylam Pharmaceuticals Inc. | 3 | $80 |
| Smith+Nephew | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$575
- Kerecis Omega3 GraftGuide$192
- Kerecis Omega3 Marigen$192
- Exogen$132
- Apligraf$115
- Dermagraft$115
- Puraply/Affinity/NuTech$115
- KRYSTEXXA$103
How this compares
$1,082 in reported general payments places this provider in the 70th percentile of 24 podiatrist providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 17 | $989 |
| CiclopiroxCiclopirox Olamine | 29 | $610 |
| Terbinafine Hcl | 28 | $249 |
| Meloxicam | 27 | $83 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Washington
- Kevin JeffersonWashington$94K
- Michael StempelWashington$5K
- Nadav AvnerWashington$4K
- Farah SiddiquiWashington$2K
- Ian BeiserWashington$2K
- Lee FirestoneWashington$2K
- Kirk GeterWashington$1K
- Sheldon LapsWashington$1K
- Lubrina BryantWashington$951
- James GirolamiWashington$718
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.